$CYCN
Cyclerion Therapeutics Inc
PRICE
$0.8171 ▼-3.233%
Extented Hours
VOLUME
139,048
DAY RANGE
0.844 - 0.92
52 WEEK
0.4613 - 3.62
Key Metrics
Market Cap
39.54 M
Beta
1.54
Avg. Volume
180.61 K
Shares Outstanding
43.45 M
Yield
0%
Public Float
0
Next Earnings Date
2022-11-08
Next Dividend Date
Company Information
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive function. Cyclerion's lead program is CY6463, a novel, first-in-class, CNS-penetrant, sGC stimulator that modulates a key node in a fundamental CNS signaling network. The multidimensional pharmacology elicited by the stimulation of sGC has the potential to impact a broad range of CNS diseases. CY6463 has shown rapid improvement in biomarkers associated with cognitive impairment and is currently in clinical development for Alzheimer's Disease with Vascular pathology (ADv) and Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS).
Website: www.cyclerion.com
HQ: ,
Related News